A detailed history of Fortitude Advisory Group L.L.C. transactions in Novo Nordisk A S stock. As of the latest transaction made, Fortitude Advisory Group L.L.C. holds 1,713 shares of NVO stock, worth $170,974. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,713
Previous 1,483 15.51%
Holding current value
$170,974
Previous $211,000 3.79%
% of portfolio
0.13%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $27,386 - $33,446
230 Added 15.51%
1,713 $203,000
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $181,978 - $217,867
1,483 New
1,483 $211,000
Q2 2022

Aug 16, 2022

SELL
$103.24 - $121.81 $34,688 - $40,928
-336 Closed
0 $0
Q4 2021

May 20, 2022

BUY
$95.88 - $117.08 $32,215 - $39,338
336 New
336 $38,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $225B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fortitude Advisory Group L.L.C. Portfolio

Follow Fortitude Advisory Group L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.